Big Money Sentiment increased to 1.17 in 2018 Q4. It has change of 0.03, from 2018Q3’s 1.14. The ratio improved due to Innophos Holdings, Inc. positioning: 24 sold and 39 reduced. 28 funds bought holdings and 46 increased holdings. Investors holded 18.36 million in 2018Q3 but now own 18.27 million shares or 0.44% less.
Loomis Sayles And Limited Partnership invested in 0% or 322 shs. Bnp Paribas Arbitrage reported 2,934 shs stake. First Mercantile Tru Company invested 0.01% of its capital in Innophos Holdings, Inc. (NASDAQ:IPHS). Segall Bryant And Hamill Ltd Liability Corp has invested 0.72% in Innophos Holdings, Inc. (NASDAQ:IPHS). 24,000 are held by Axa. Sei invested in 36,838 shs. Penn Mgmt owns 116,527 shs or 0.28% of their US capital. Quantitative Systematic Strategies Limited Co has invested 0.05% in Innophos Holdings, Inc. (NASDAQ:IPHS). Kennedy Capital Mngmt Inc owns 0.32% invested in Innophos Holdings, Inc. (NASDAQ:IPHS) for 518,061 shs. Huntington National Bank & Trust has 1 shs. Curbstone Mngmt accumulated 11,400 shs. Fmr Ltd Com owns 94 shs. Panagora Asset Mgmt holds 0% or 3,609 shs. Parametric Associate Ltd Limited Liability Company holds 114,980 shs. Charles Schwab Invest Inc reported 251,735 shs or 0% of all its holdings.

Innophos Holdings, Inc. (NASDAQ:IPHS) is awaited to reveal earnings on May, 7., according to RTT. earnings per share of $0.43 is 29.51 % down from 2018’s $0.61 EPS. If earnings per share of $0.43 is reported the profit of IPHS could hit $8.43M giving it 18.69 P/E. Wall Street now forecasts -20.37 % negative EPS growth despite Innophos Holdings, Inc. last quarter’s EPS of $0.54. IPHS touched $32.15 during the last trading session after $0.45 change.Innophos Holdings, Inc. has volume of 104,444 shares. Since April 6, 2018 IPHS has declined 19.27% and is downtrending. The stock underperformed the S&P 500 by 23.64%.

Innophos Holdings, Inc., through its subsidiaries, produces performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care, and industrial end markets.The firm is worth $630.56 million. It operates through Food, Health & Nutrition, Industrial Specialties, and Other divisions.The P/E ratio is 17.66. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture additives in cheeses; leavening agents in baked goods; mineral and botanical sources for nutritional supplements; pharmaceutical excipients; and abrasives in toothpaste, as well as in industrial applications, such as asphalt modification and petrochemical catalysis.

For more Innophos Holdings, Inc. (NASDAQ:IPHS) news published briefly go to: Nasdaq.com, Nasdaq.com, Seekingalpha.com, Businesswire.com or Seekingalpha.com. The titles are as follows: “Q1 Earnings Season Good, But Not Great – Nasdaq” published on April 27, 2018, “Earnings Season Shows Strong Revenue Momentum – Nasdaq” on July 27, 2018, “Innophos Holdings, Inc. 2016 Q2 – Results – Earnings Call Slides – Seeking Alpha” with a publish date: August 02, 2016, “Innophos Appoints Eugenia Erlij as Vice President, Marketing – Business Wire” and the last “Innophos – 2022 Targets Look Too Ambitious After A Softer 2017 – Seeking Alpha” with publication date: April 06, 2017.